Acuity Law Reveals Role In £1.13 Million Seed Funding For London-Based Healthtech, HealthKey

Acuity Law Reveals Role In £1.13 Million Seed Funding For London-Based Healthtech, HealthKey

Acuity Law has advised HealthKey,  a London-based healthtech that aims to transform how healthcare is paid for, in its £1.13 million seed funding round.

Acuity acted for HealthKey in the funding round, in which Aviva Ventures led an investment consortium including Ascension, Oxford Capital and Cur8 Capital.

HealthKey, which provides easy access to affordable, specialised health services, will use this substantial investment to expand and enhance its platform, as well as grow the number of vetted health providers included on it. At the moment, these include companies providing neurodiversity care, LGBTQ+ wellbeing, pain management, fertility, addiction and more.

London-based Acuity Law partner Andrew McGlashan said: “We are delighted to have supported HealthKey in securing this substantial seed funding. HealthKey’s innovative healthcare platform is an important tool for improving access to preventative healthcare, and we are very pleased to be able to support the company as it grows and expands its services.”

Co-founder and CEO David Joerring said: “Andrew and the rest of the team at Acuity have been an incredible support in reaching this next phase of growth at HealthKey. We look forward to working with Acuity as we continue to change the way healthcare is paid for and widen access to health-related information and life-improving services so that people can be proactive about their health.”